- Home
- FTRE vs BCAT Comparison
FTRE vs BCAT Comparison
Compare FTRE & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- BCAT
- Stock Information
- Founded
- FTRE 1996
- BCAT 2020
- Country
- FTRE United States
- BCAT United States
- Employees
- FTRE N/A
- BCAT N/A
- Industry
- FTRE Medical Specialities
- BCAT Finance/Investors Services
- Sector
- FTRE Health Care
- BCAT Finance
- Exchange
- FTRE Nasdaq
- BCAT Nasdaq
- Market Cap
- FTRE 469.0M
- BCAT 1.5B
- IPO Year
- FTRE N/A
- BCAT N/A
- Fundamental
- Price
- FTRE $5.95
- BCAT $14.78
- Analyst Decision
- FTRE Hold
- BCAT
- Analyst Count
- FTRE 11
- BCAT 0
- Target Price
- FTRE $18.00
- BCAT N/A
- AVG Volume (30 Days)
- FTRE 2.3M
- BCAT 308.8K
- Earning Date
- FTRE 05-12-2025
- BCAT 01-01-0001
- Dividend Yield
- FTRE N/A
- BCAT 9.38%
- EPS Growth
- FTRE N/A
- BCAT N/A
- EPS
- FTRE N/A
- BCAT 1.43
- Revenue
- FTRE $2,696,400,000.00
- BCAT N/A
- Revenue This Year
- FTRE N/A
- BCAT N/A
- Revenue Next Year
- FTRE $3.32
- BCAT N/A
- P/E Ratio
- FTRE N/A
- BCAT $11.41
- Revenue Growth
- FTRE N/A
- BCAT N/A
- 52 Week Low
- FTRE $4.77
- BCAT $13.67
- 52 Week High
- FTRE $37.24
- BCAT $16.38
- Technical
- Relative Strength Index (RSI)
- FTRE 43.28
- BCAT 60.61
- Support Level
- FTRE $5.40
- BCAT $14.60
- Resistance Level
- FTRE $6.38
- BCAT $14.49
- Average True Range (ATR)
- FTRE 0.45
- BCAT 0.19
- MACD
- FTRE 0.21
- BCAT 0.10
- Stochastic Oscillator
- FTRE 72.52
- BCAT 92.75
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.